Amy Sehnert is a Cardiology physician affiliated with Bristol-Myers Squibb. OpenAlex indexes 129 publications with 11,383 citations (h-index 40); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Welch Rd
Palo Alto, CA 943041601
Telephone
650-498-7103Registry record last updated 8 Jul 2007.
Clinical trials
- Comparison of Aneuploidy Risk Evaluations
Sponsor: Verinata Health, Inc.
- MatErnal BLood IS Source to Accurately Diagnose Fetal Aneuploidy
Sponsor: Verinata Health, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
2 NIH research awards on record, funded 1999–2005 per NIH RePORTER. The latest:
- GENETIC ANALYSIS OF HYPERTROPHIC CARDIOMYOPATHY
University of California San Francisco
FY2005$28,989M01RR001271 - Genetic analysis of hypertrophic cardiomyopathy
University of California San Francisco
FY2004$21,422M01RR001271 - CARDIAC TROPONIN T MUTATIONS AND HEART FUNCTION
University of California San Francisco
FY2003$121,770K08HL004068
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM
JACC. Cardiovascular imaging
2024 - Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial
Circulation Cardiovascular Imaging
2024 - Long‐Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER‐OLE Study
Journal of the American Heart Association
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Alan J. Korman
Bristol-Myers Squibb
Ray Hershberger, MD
Bristol-Myers Squibb
Theodore Abraham, MD
Bristol-Myers Squibb
Elizabeth M. Johnson
Bristol-Myers Squibb
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”